Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1955 1
1956 1
1957 4
1958 1
1959 3
1960 2
1961 4
1962 7
1963 5
1964 10
1965 9
1966 5
1967 3
1968 8
1969 3
1970 1
1971 5
1972 6
1973 6
1974 6
1975 7
1976 11
1977 6
1978 6
1979 20
1980 24
1981 19
1982 25
1983 25
1984 30
1985 40
1986 55
1987 69
1988 90
1989 85
1990 91
1991 95
1992 115
1993 135
1994 169
1995 175
1996 234
1997 243
1998 263
1999 271
2000 356
2001 412
2002 464
2003 672
2004 797
2005 1032
2006 1241
2007 1385
2008 1587
2009 1869
2010 2247
2011 2688
2012 3187
2013 3804
2014 4380
2015 5127
2016 5423
2017 6065
2018 7009
2019 7811
2020 9615
2021 10899
2022 13053
2023 13012
2024 13999
2025 144

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108,278 results

Results by year

Filters applied: . Clear all
Page 1
Direct cell reprogramming: approaches, mechanisms and progress.
Wang H, Yang Y, Liu J, Qian L. Wang H, et al. Among authors: yang y. Nat Rev Mol Cell Biol. 2021 Jun;22(6):410-424. doi: 10.1038/s41580-021-00335-z. Epub 2021 Feb 22. Nat Rev Mol Cell Biol. 2021. PMID: 33619373 Free PMC article. Review.
Epilepsy and long-term risk of arrhythmias.
Wang J, Huang P, Yu Q, Lu J, Liu P, Yang Y, Feng Z, Cai J, Yang G, Yuan H, Tang H, Lu Y. Wang J, et al. Among authors: yang y. Eur Heart J. 2023 Sep 14;44(35):3374-3382. doi: 10.1093/eurheartj/ehad523. Eur Heart J. 2023. PMID: 37602368 Free PMC article.
Editorial: Cardiovascular remodeling.
Yang Y, Zhang Y, Li GR, Lei M. Yang Y, et al. Front Pharmacol. 2023 Jul 24;14:1252598. doi: 10.3389/fphar.2023.1252598. eCollection 2023. Front Pharmacol. 2023. PMID: 37554980 Free PMC article.
VEGF-B prevents excessive angiogenesis by inhibiting FGF2/FGFR1 pathway.
Lee C, Chen R, Sun G, Liu X, Lin X, He C, Xing L, Liu L, Jensen LD, Kumar A, Langer HF, Ren X, Zhang J, Huang L, Yin X, Kim J, Zhu J, Huang G, Li J, Lu W, Chen W, Liu J, Hu J, Sun Q, Lu W, Fang L, Wang S, Kuang H, Zhang Y, Tian G, Mi J, Kang BA, Narazaki M, Prodeus A, Schoonjans L, Ornitz DM, Gariepy J, Eelen G, Dewerchin M, Yang Y, Ou JS, Mora A, Yao J, Zhao C, Liu Y, Carmeliet P, Cao Y, Li X. Lee C, et al. Among authors: yang y. Signal Transduct Target Ther. 2023 Aug 18;8(1):305. doi: 10.1038/s41392-023-01539-9. Signal Transduct Target Ther. 2023. PMID: 37591843 Free PMC article.
Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.
Kyle SD, Siriwardena AN, Espie CA, Yang Y, Petrou S, Ogburn E, Begum N, Maurer LF, Robinson B, Gardner C, Lee V, Armstrong S, Pattinson J, Mort S, Temple E, Harris V, Yu LM, Bower P, Aveyard P. Kyle SD, et al. Among authors: yang y. Lancet. 2023 Sep 16;402(10406):975-987. doi: 10.1016/S0140-6736(23)00683-9. Epub 2023 Aug 10. Lancet. 2023. PMID: 37573859 Free article. Clinical Trial.
Covalent conjugation of extracellular vesicles with peptides and nanobodies for targeted therapeutic delivery.
Pham TC, Jayasinghe MK, Pham TT, Yang Y, Wei L, Usman WM, Chen H, Pirisinu M, Gong J, Kim S, Peng B, Wang W, Chan C, Ma V, Nguyen NTH, Kappei D, Nguyen XH, Cho WC, Shi J, Le MTN. Pham TC, et al. Among authors: yang y. J Extracell Vesicles. 2021 Feb;10(4):e12057. doi: 10.1002/jev2.12057. Epub 2021 Feb 16. J Extracell Vesicles. 2021. PMID: 33643546 Free PMC article.
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial.
Yang Y, Min J, Yang N, Yu Q, Cheng Y, Zhao Y, Li M, Chen H, Ren S, Zhou J, Zhuang W, Qin X, Cao L, Yu Y, Zhang J, He J, Feng J, Yu H, Zhang L, Fang W. Yang Y, et al. Signal Transduct Target Ther. 2023 Aug 14;8(1):301. doi: 10.1038/s41392-023-01538-w. Signal Transduct Target Ther. 2023. PMID: 37574511 Free PMC article. Clinical Trial.
108,278 results
You have reached the last available page of results. Please see the User Guide for more information.